Related Experiment Videos
Refractory generalised convulsive status epilepticus : a guide to treatment
Reetta Kälviäinen1, Kai Eriksson, Ilkka Parviainen
1Department of Neurology, Kuopio University Hospital and University of Kuopio, Kuopio, Finland. reetta.kalviainen@kuh.fi
CNS Drugs
|September 7, 2005
Summary
Refractory generalized convulsive status epilepticus (GCSE) is a life-threatening condition requiring intensive care. Current treatments, primarily barbiturates, are effective but associated with high mortality, necessitating novel therapeutic strategies.
Area of Science:
- Neurology
- Critical Care Medicine
Background:
- Generalized convulsive status epilepticus (GCSE) is a medical emergency characterized by continuous or rapidly recurring seizures.
- Refractory GCSE, unresponsive to first- and second-line antiepileptic drugs, presents significant management challenges and carries a high mortality rate.
Framework:
- Management of refractory GCSE necessitates intensive care unit admission with artificial ventilation, hemodynamic support, and continuous electroencephalogram (EEG) monitoring.
- Treatment involves high-dose intravenous anesthetics, primarily barbiturates (pentobarbital, thiopental sodium), to abolish seizure activity.
Implementation:
- Continuous intravenous anesthetics are titrated to achieve burst suppression on EEG.
- Hemodynamic support with intravenous fluids and vasopressors is crucial to manage hypotension.
- Gradual tapering of anesthetics is performed under continuous EEG monitoring, with concurrent administration of other antiepileptic drugs like phenytoin or valproate to prevent seizure recurrence.
Implications:
- Despite aggressive management, refractory GCSE has a ~50% mortality rate and often results in significant neurological deficits.
- There is an urgent need for novel therapeutic agents with improved efficacy, safety, and neuroprotective properties for refractory GCSE.